Literature DB >> 1349446

A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201.

M Congia1, F Frau, R Lampis, R Frau, R Mele, F Cucca, F Muntoni, S Porcu, F Boi, L Contu.   

Abstract

This study characterizes by serological and molecular methods the HLA class I and class II alleles in a group of celiac disease children, their parents and a control group of Sardinian descent. We found the DR3-DQw2 haplotype in all patients which was, in almost all cases (84%), associated with the HLA-A30, B18, DR3, DRw52, DQw2 extended haplotype named "Sardinian haplotype" because of its frequency (12-15%) in this Caucasian population. This is the first time that this DQw2-linked haplotype has been reported with such a high frequency in CD. However, no different distribution of "Sardinian haplotype" was found comparing CD patients with 91 haplotyped DQw2-positive controls. This finding indicates that the DQw2 antigen in Sardinians is almost always associated with the A30, B18, DR3, DRw52, DQw2 extended haplotype. The DQA1 and DQB1 second exon sequence analysis of the B18,DR3 and B8,DR3 haplotypes showed the DQA1*0501 and DQB1*0201 alleles which shared the already published sequences. DPB1 subtyping showed the DPB1*0301 allele more frequently (p less than 0.005) in CD patients but this difference was no longer significant when patients and controls, both heterozygous for the DR3-DQw2 haplotype, were compared. We suggest that the divergent HLA extended haplotypes and DP allele associated with CD, described in different Caucasian populations, can be explained by the particular DQw2 linkage disequilibrium in each population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349446     DOI: 10.1111/j.1399-0039.1992.tb01911.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Differing clinical manifestations of celiac disease transmitted by bone marrow transplantation.

Authors:  Mark R Borgaonkar; Peter R Duggan; Grenfell Adams
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.

Authors:  Owen D Solberg; Steven J Mack; Alex K Lancaster; Richard M Single; Yingssu Tsai; Alicia Sanchez-Mazas; Glenys Thomson
Journal:  Hum Immunol       Date:  2008-06-09       Impact factor: 2.850

3.  Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.

Authors:  H W Schroeder; Z B Zhu; R E March; R D Campbell; S M Berney; S A Nedospasov; R L Turetskaya; T P Atkinson; R C Go; M D Cooper; J E Volanakis
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

Review 4.  The roles of MHC class II genes and post-translational modification in celiac disease.

Authors:  Ludvig M Sollid
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

5.  Molecular biology of coeliac disease.

Authors:  R Tighe; P J Ciclitira
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

6.  Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region.

Authors:  F Cucca; Z B Zhu; A Khanna; F Cossu; M Congia; M Badiali; R Lampis; F Frau; S De Virgiliis; A Cao; M Arnone; P Piras; R D Campbell; M D Cooper; J E Volanakis; S H Powis
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  High-resolution analysis of the HLA-A, -B, -C and -DRB1 alleles and national and regional haplotype frequencies based on 120 926 volunteers from the Italian Bone Marrow Donor Registry.

Authors:  Nicoletta Sacchi; Mauro Castagnetta; Valeria Miotti; Lucia Garbarino; Annamaria Gallina
Journal:  HLA       Date:  2019-07-03       Impact factor: 4.513

Review 8.  Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients.

Authors:  Giovanni Marasco; Giovanna Grazia Cirota; Benedetta Rossini; Lisa Lungaro; Anna Rita Di Biase; Antonio Colecchia; Umberto Volta; Roberto De Giorgio; Davide Festi; Giacomo Caio
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

9.  Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Authors:  A M Gravett; N Trautwein; S Stevanović; A G Dalgleish; J Copier
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.